Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Evaluation of the Value of Using an MTor Inhibitor (everolimus) for the Minimisation of Anticalceurins in Old-for-old Kidney Transplantation

NCT06504225 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT06504225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06504225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Evaluation of the Value of Using an MTor Inhibitor (everolimus) for the Minimisation of Anticalceurins in Old-for-old Kidney Transplantation
Lead sponsor
University Hospital, Brest
Phase
Observational
Overall status
Recruiting
Start date
August 23, 2024
Completion date
August 1, 2025
Enrollment
260 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

transplant; complication, failure